SUMI DAI PHARMA (DPM.SG)
SUMI DAI PHARMA (DPM.SG) operates in Diversified Metals & Mining.
SUMI DAI PHARMA (DPM.SG) (DPM) - Total Assets
Latest total assets as of March 2024: €907.51 Billion EUR
Based on the latest financial reports, SUMI DAI PHARMA (DPM.SG) (DPM) holds total assets worth €907.51 Billion EUR as of March 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SUMI DAI PHARMA (DPM.SG) - Total Assets Trend (2017–2024)
This chart illustrates how SUMI DAI PHARMA (DPM.SG)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
SUMI DAI PHARMA (DPM.SG) - Asset Composition Analysis
Current Asset Composition (March 2024)
SUMI DAI PHARMA (DPM.SG)'s total assets of €907.51 Billion consist of 29.7% current assets and 70.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.2% |
| Accounts Receivable | €81.02 Billion | 8.9% |
| Inventory | €115.35 Billion | 12.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €195.65 Billion | 21.6% |
| Goodwill | €199.78 Billion | 22.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how SUMI DAI PHARMA (DPM.SG)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SUMI DAI PHARMA (DPM.SG)'s current assets represent 29.7% of total assets in 2024, a decrease from 47.4% in 2017.
- Cash Position: Cash and equivalents constituted 3.2% of total assets in 2024, down from 9.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 43.0% of total assets, an increase from 37.0% in 2017.
- Asset Diversification: The largest asset category is goodwill at 22.0% of total assets.
SUMI DAI PHARMA (DPM.SG) Competitors by Total Assets
Key competitors of SUMI DAI PHARMA (DPM.SG) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
SUMI DAI PHARMA (DPM.SG) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - SUMI DAI PHARMA (DPM.SG) generates 0.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - SUMI DAI PHARMA (DPM.SG) is currently not profitable relative to its asset base.
SUMI DAI PHARMA (DPM.SG) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.52 | 1.02 | 1.89 |
| Quick Ratio | 0.30 | 0.77 | 1.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-245.91 Billion | € 9.17 Billion | € 172.83 Billion |
SUMI DAI PHARMA (DPM.SG) - Advanced Valuation Insights
This section examines the relationship between SUMI DAI PHARMA (DPM.SG)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -20.0% |
| Total Assets | €907.51 Billion |
| Market Capitalization | $93.88K USD |
Valuation Analysis
Below Book Valuation: The market values SUMI DAI PHARMA (DPM.SG)'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: SUMI DAI PHARMA (DPM.SG)'s assets decreased by 20.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for SUMI DAI PHARMA (DPM.SG) (2017–2024)
The table below shows the annual total assets of SUMI DAI PHARMA (DPM.SG) from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-03-31 | €907.51 Billion | -20.03% |
| 2023-03-31 | €1.13 Trillion | -13.25% |
| 2022-03-31 | €1.31 Trillion | -0.01% |
| 2021-03-31 | €1.31 Trillion | +4.41% |
| 2020-03-31 | €1.25 Trillion | +50.10% |
| 2019-03-31 | €834.72 Billion | +3.09% |
| 2018-03-31 | €809.68 Billion | +1.98% |
| 2017-03-31 | €793.95 Billion | -- |